US 100% pharma tariff kicks in; India gets key exemptions for rare-disease drugs, gene and cell therapies

The exemptions form part of the implementation of Trump's April proclamation adjusting imports of pharmaceuticals and pharmaceutical ingredients under Section 232 of the Trade Expansion Act